Fazpilodemab (BFKB8488A) 是一种靶向成纤维细胞生长因子受体 1c (FGFR1c) 和Klothoβ的人源化、激动性双特异性抗体。 Fazpilodemab 可用于 2 型糖尿病 (T2DM) 或非酒精性脂肪性肝病 (NAFLD) 的研究。
| 生物活性 | Fazpilodemab (BFKB8488A) is a humanized, agonistic, bispecific antibody targetingfibroblast growth factorreceptor 1c (FGFR1c) andKlothoβ. Fazpilodemab can be used for the research of type 2 diabetes mellitus (T2DM) or nonalcoholic fatty liver disease (NAFLD)[1]. |
| IC50& Target[1] | |
| CAS 号 | |
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
m.cnreagent.com